Showing 81-100 of 214 for: Cochrane Systematic Reviews > Renal 
- Exercise training for adults with chronic kidney disease
Cochrane Systematic Reviews, 4-Sep-2011
Chronic kidney disease (CKD) is a worldwide public health problem. In the National Kidney Foundation Disease Outcomes Quality Initiative guidelines it is stressed that lifestyle issues such as physical activity should be seen as cornerstones of the therap
- Extracorporeal shock wave lithotripsy (ESWL) versus percutaneous nephrolithotomy (PCNL) or retrograde intrarenal surgery (RIRS) for kidney stones
Cochrane Systematic Reviews, 17-Nov-2014
Stones in the urinary tract are a common medical problem in the general population. At present, the great expansion in minimally invasive techniques has led to the decrease in open surgery. Extracorporeal shock wave lithotripsy (ESWL) has been introduced
- Extracorporeal shock wave lithotripsy (ESWL) versus ureteroscopic management for ureteric calculi
Cochrane Systematic Reviews, 16-May-2012
Ureteral stones frequently cause renal colic, and if left untreated, can lead to obstructive uropathy. Extracorporeal shock wave lithotripsy (ESWL) and ureteroscopy, with or without intracorporeal lithotripsy, are the most common interventions used to tre
- Fish oil for kidney transplant recipients
Cochrane Systematic Reviews, 18-Aug-2016
Calcineurin inhibitors used in kidney transplantation for immunosuppression have adverse effects that may contribute to nephrotoxicity and increased cardiovascular risk profile. Fish oils are rich in very long chain omega-3 fatty acids, which may reduce n
- Fluids and diuretics for acute ureteric colic
Cochrane Systematic Reviews, 15-Feb-2012
Acute ureteric colic is commonly associated with severe and debilitating pain. Theoretically, increasing fluid flow through the affected kidney might expedite stone passage, thereby improving symptoms more quickly. The efficacy and safety of interventions
- Fluoroquinolones for treating tuberculosis (presumed drug‐sensitive)
Cochrane Systematic Reviews, 6-Jun-2013
Currently the World Health Organization only recommend fluoroquinolones for people with presumed drug-sensitive tuberculosis (TB) who cannot take standard first-line drugs. However, use of fluoroquinolones could shorten the length of treatment and improve
- Fluoroquinolones for treating typhoid and paratyphoid fever (enteric fever)
Cochrane Systematic Reviews, 16-Nov-2011
Typhoid and paratyphoid are febrile illnesses, due to a bacterial infection, which remain common in many low- and middle-income countries. The World Health Organization (WHO) currently recommends the fluoroquinolone antibiotics in areas with known resista
- Frequency of administration of erythropoiesis‐stimulating agents for the anaemia of end‐stage kidney disease in dialysis patients
Cochrane Systematic Reviews, 28-May-2014
The benefits of erythropoiesis-stimulating agents (ESA) for dialysis patients have been demonstrated. However, it remains unclear whether the efficacy and safety of new, longer-acting ESA given less frequently is equivalent to recombinant human erythropoi
- Furosemide for prevention of morbidity in indomethacin‐treated infants with patent ductus arteriosus
Cochrane Systematic Reviews, 23-Jul-2001
Inhibition of prostaglandin synthesis mediates closure of the ductus arteriosus and renal side effects after indomethacin administration. Because furosemide increases prostaglandin production, it could potentially help prevent indomethacin-related toxicit
- Gemcitabine for unresectable, locally advanced or metastatic bladder cancer
Cochrane Systematic Reviews, 1-Mar-2011
The prognosis for unresectable, locally advanced or metastatic transitional cell carcinoma of the bladder is poor with most patients succumbing to their disease within 2 to 3 years. Clinical management at this stage of the disease is palliative with syste
- Gold as an oral corticosteroid sparing agent in stable asthma
Cochrane Systematic Reviews, 23-Oct-2000
Patients with chronic severe asthma are often dependent on the long term prescription of oral corticosteroids. The use of steroids is associated with serious side effects. Physicians treating such patients continue to search for alternative therapies that
- Growth hormone for children with chronic kidney disease
Cochrane Systematic Reviews, 15-Feb-2012
Growth retardation is a common complication of chronic kidney disease (CKD) in children and is of concern to families. Recombinant human growth hormone (rhGH) treatment has been used to help short children with CKD attain a height more in keeping with the
- Habit retraining for the management of urinary incontinence in adults
Cochrane Systematic Reviews, 6-Sep-2009
Habit retraining is a form of toileting assistance given by a caregiver to adults with urinary incontinence. It involves the identification of an incontinent person's natural voiding pattern and the development of an individualised toileting schedule, whi
- Haemodiafiltration, haemofiltration and haemodialysis for end-stage kidney disease
Cochrane Systematic Reviews, 14-May-2015
Convective dialysis modalities (haemofiltration (HF), haemodiafiltration (HDF), and acetate-free biofiltration (AFB)) removed excess body fluid across the dialysis membrane with positive pressure and accumulated middle- and larger-size accumulated solutes
- Haemoglobin and haematocrit targets for the anaemia of chronic kidney disease
Cochrane Systematic Reviews, 13-Jan-2010
Anaemia affects 60% to 80% of patients with chronic kidney disease (CKD) reduces quality of life and is a risk factor for early death. Treatment options are blood transfusion, erythropoietin (EPO) and darbepoetin alfa. Recently higher haemoglobin (Hb) and
- Hawthorn extract for treating chronic heart failure
Cochrane Systematic Reviews, 20-Nov-2013
Hawthorn extract is advocated as an oral treatment option for chronic heart failure. Also, the German Commission E approved the use of extracts of hawthorn leaf with flower in patients suffering from heart failure graded stage II according to the New York
- Heparin and related substances for preventing diabetic kidney disease
Cochrane Systematic Reviews, 1-Aug-2010
Diabetic kidney disease (DKD, also called diabetic nephropathy, DN) is the major cause of end-stage kidney disease (ESKD) in many countries and is associated with increased morbidity and mortality as compared to other causes of kidney disease. One of the
- Hepatitis B vaccination for patients with chronic renal failure
Cochrane Systematic Reviews, 19-Jul-2004
Chronic renal failure patients are at particular risk of hepatitis B virus infection. Early studies have demonstrated that renal failure patients benefit from vaccination; however, not all studies have consistently shown benefit.
- High‐flux versus low‐flux membranes for end‐stage kidney disease
Cochrane Systematic Reviews, 12-Sep-2012
Clinical practice guidelines regarding the use of high-flux haemodialysis membranes vary widely.
- HMG CoA reductase inhibitors (statins) for dialysis patients
Cochrane Systematic Reviews, 2-Sep-2013
People with advanced kidney disease treated with dialysis experience mortality rates from cardiovascular disease that are substantially higher than for the general population. Studies that have assessed the benefits of statins (HMG CoA reductase inhibitor
